These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents. Kapusta MA; Dumont C J Rheumatol; 2008 Oct; 35(10):2077-80. PubMed ID: 18843767 [No Abstract] [Full Text] [Related]
23. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309 [TBL] [Abstract][Full Text] [Related]
29. Treatment of severe nail psoriasis with etanercept. Coelho JD; Diamantino F; Lestre S; Ferreira AM Indian J Dermatol Venereol Leprol; 2011; 77(1):72-4. PubMed ID: 21220889 [No Abstract] [Full Text] [Related]
30. Nail dystrophy in psoriatic arthritis presenting as nail onychomycosis: a case report. Kim JY; Baek GH; Gong HS Hand Surg; 2012; 17(1):139-42. PubMed ID: 22351553 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study. Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153 [TBL] [Abstract][Full Text] [Related]
32. Nail Psoriasis Treated With Certolizumab Pegol in Patients With Psoriatic Arthritis: Preliminary Observation. Mazzeo M; Dattola A; Cannizzaro MV; Bianchi L Actas Dermosifiliogr (Engl Ed); 2019 Mar; 110(2):169-171. PubMed ID: 29866366 [No Abstract] [Full Text] [Related]
34. A case of nail psoriasis-associated psoriatic arthritis successfully treated with adalimumab. Ikumi N; Kitamura N; Shiraiwa H; Inomata H; Nozaki T; Kuwana Y; Matsukawa Y; Hayama T; Sawada S; Takei M; Ochiai T Acta Dermatovenerol Croat; 2014; 22(1):65-6. PubMed ID: 24813847 [No Abstract] [Full Text] [Related]
35. Pachydermoperiostosis and psoriatic onychopathy: an unusual association. Fietta P; Manganelli P J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):73-6. PubMed ID: 12602977 [TBL] [Abstract][Full Text] [Related]
36. Nail psoriasis treated with intralesional methotrexate infiltration. Duarte AA; Carneiro GP; Murari CM; Jesus LCB An Bras Dermatol; 2019; 94(4):491-492. PubMed ID: 31644634 [No Abstract] [Full Text] [Related]
37. Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis. Augustin M; Mrowietz U; Willsmann-Theis D; Gerdes S; Fotiou K; Schuster C; Mert C; Holzkaemper T; Behrens F; Pinter A J Dtsch Dermatol Ges; 2024 Feb; 22(2):278-281. PubMed ID: 38185772 [No Abstract] [Full Text] [Related]
38. Severe 20-nail psoriasis successfully treated by low dose methotrexate. Lee JY Dermatol Online J; 2009 Nov; 15(11):8. PubMed ID: 19951644 [TBL] [Abstract][Full Text] [Related]
39. Interventions for nail psoriasis. de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816 [TBL] [Abstract][Full Text] [Related]
40. Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. De Simone C; Maiorino A; Tassone F; D'Agostino M; Caldarola G J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1003-6. PubMed ID: 22788697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]